Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04036058 · ClinicalTrials.gov registry record · NA
Effect of Expanding (Gloving) Barrier Precautions for Reducing Clostridium Difficile Acquisition (and Infection) in VA
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 780
- Enrollment target
NCT04036058: Completed NA study, sponsored by VA Office of Research and Development.
NCT04036058 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 780 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04036058, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 780 participants
- Enrollment target
Study Summary
Clostridium difficile (C. difficile) is a major pathogen causing serious healthcare-associated diarrheal illness in patients. Prevention of healthcare facility-onset C. difficile infection (CDI) is essential. Many CDI cases are caused by the transmission of the pathogen from patients who carry the bacteria, but do not have symptoms. However, there are limited data on how to prevent the transmission of C. difficile from patients who do not have symptoms. Universal gloving practices - the use of gloves by all healthcare workers for all patient contacts - may reduce CDI cases. In this study, the investigators will examine the effectiveness of universal gloving practices as compared to standard of care (use of gloving for contact only in patients with known CDI or other infections). The investigators will compare the effects of these practices on the transmission of C. difficile within participating hospital units to determine if universal gloving is an effective practice to prevent healthcare-associated CDI.
Interventions
- OTHER Universal gloving
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 780 participants |
| Start Date | 2022-03-29 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04036058
The ClinicalTrials.gov registry entry for NCT04036058 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 780 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Universal gloving is the first listed.
NCT04036058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04036058 about?
NCT04036058 is a clinical study titled "Effect of Expanding (Gloving) Barrier Precautions for Reducing Clostridium Difficile Acquisition (and Infection) in VA". Clostridium difficile (C. difficile) is a major pathogen causing serious healthcare-associated diarrheal illness in patients. Prevention of healthcare facility-onset C. difficile infection (CDI) is essential. Many CDI cases are caused by the transmission of the pathogen from patients who carry the b...
What is the current status of trial NCT04036058?
This trial is currently completed. It is a NA study. The enrollment target is 780 participants. The study started on 2022-03-29. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT04036058?
The interventions under investigation include: Universal gloving (OTHER).
Who is sponsoring clinical trial NCT04036058?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.